Ahmedabad, Gujarat, India, February 2026 — Intas Pharmaceuticals has appointed Amit Pawar as Associate Vice President, reinforcing the company’s commitment to strengthening its leadership structure amid continued global growth and operational expansion.
A dynamic organization known for innovation, quality manufacturing, and long-term strategic vision, Intas Pharmaceuticals continues to expand its footprint across the global pharmaceutical landscape. Pawar’s elevation reflects the company’s focus on experienced leadership to drive operational excellence and transformation.
Pawar has been associated with Intas Pharmaceuticals for nearly 15 years, steadily advancing through key leadership roles including General Manager and Senior General Manager before taking charge as Associate Vice President in January 2026. Over the years, he has contributed significantly to manufacturing operations, engineering projects, process optimization, and strategic scale-up initiatives within the biopharmaceutical domain.
Earlier in his professional journey, he worked with Mabpharm Private Limited, Cipla Ltd., and Gennova Biopharmaceuticals, where he built deep expertise in therapeutic protein purification, production scale-up, and biopharmaceutical process development. His experience across leading pharmaceutical organizations has shaped a strong foundation in manufacturing strategy, operational leadership, and high-impact execution.
Pawar holds an Executive MBA in Operations Management from the Indian Institute of Management Kozhikode and a Master of Technology in Pharmaceutical Operations and Management from Birla Institute of Technology and Science, Pilani, further strengthening his strategic and operational capabilities.
With strong strategic thinking and an execution-focused mindset, Pawar aims to enhance operational performance and lead purposeful transformation initiatives, steering Intas Pharmaceuticals toward new milestones in the years ahead.
About Intas Pharmaceuticals
Intas Pharmaceuticals is a leading multinational pharmaceutical formulation development, manufacturing, and marketing organization operating in over 85 countries. Ranked among the top pharmaceutical companies in India, Intas has a strong presence in regulated markets including the EU, US, and UK. With 17 advanced facilities and over 23,000 employees globally, the company continues to invest in R&D and innovation, particularly in biosimilars and plasma-derived therapeutics, under its mission to deliver affordable healthcare solutions worldwide.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
